title: In-vitro susceptibility of Haemophilus influenzae to loracarbef (LY 163892) and other oral antibiotics. Collaborative Study Group on Pediatric Infectious Disease in Lombardy.
abstract: Data on susceptibility of Haemophilus influenzae are scanty in Italy. We compared the activity of loracarbef (Ly 163892), a new carbacephem, with that of 4 other agents against 265 strains of H. influenzae (46 type b, 219 nontypable) isolated from adults and children at Istituti Clinici di Perfezionamento of Milano, between 1/1/84 and 1/1/89, and also from 7 children at pediatric departments in Lombardy during 1988. In adults 72 strains were all isolated from sputum of patients with pneumonia or chronic bronchitis; in children 199 strains were isolated from conjunctiva (53% of the patients had also a concomitant respiratory infection), 24 from middle ear, 18 from sputum and 32 from blood or cerebrospinal fluid. Minimal inhibiting concentrations (MIC) were determined by the broth microdilution technique. The incidence of resistance of H. influenzae to ampicillin was 3.8%; the lowest percentage of resistance was found for loracarbef (0%) and the highest for erythromycin (94% for strains isolated from children and 97% for strains isolated from adults).
authors.affiliation: Laboratory of Microbiology, Istituti Clinici di Perfezionamento, Milano, Italy.
authors.forename: M L
authors.initials: ML
authors.lastname: Garlaschi
authors.forename: R
authors.initials: R
authors.lastname: Colombo
authors.forename: F
authors.initials: F
authors.lastname: Varotto
authors.forename: F
authors.initials: F
authors.lastname: Conio
authors.forename: F
authors.initials: F
authors.lastname: Rusconi
authors.forename: S
authors.initials: S
authors.lastname: Sideri
authors.forename: L
authors.initials: L
authors.lastname: Gagliardi
authors.forename: A
authors.initials: A
authors.lastname: Sala
authors.forename: M
authors.initials: M
authors.lastname: Arghittu
mesh_terms: D000328:Adult; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D002648:Child; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000494:pharmacology; D006192:Haemophilus Infections / Q000188:drug therapy*; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; C054920:loracarbef; D004917:Erythromycin; D000667:Ampicillin